NCT05070858: An ongoing trial by Regeneron Pharmaceuticals
This trial is ongoing. It must report results 7 months, 1 week from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05070858 |
|---|---|
| Title | Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Monotherapy in Patients With Symptomatic Generalized Myasthenia Gravis |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 14, 2021 |
| Completion date | July 18, 2025 |
| Required reporting date | July 18, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |